NCT02386488

Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women

A Randomised, Open-label, Single-centre, Single- and Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 64 (actual)
• Sponsor: H. Lundbeck A/S · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the pharmacokinetic (PK) parameters of vortioxetine after single and multiple oral dosing to healthy Chinese men and women.

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	Vortioxetine 10 mg single dose	10 mg tablet for oral use, single dose
DRUG	Vortioxetine 20 mg single dose	Two 10 mg tablets for oral use, single dose,
DRUG	Vortioxetine 10 mg multiple dose	10 mg tablet for oral use once, daily for 14 days.
DRUG	Vortioxetine 20 mg multiple dose	Two 10 mg tablets for oral use, once daily for 14 days.

Timeline

• Start date: 2015-03-01
• Primary completion: 2015-05-01
• Completion: 2015-05-01
• First posted: 2015-03-12
• Last updated: 2015-05-19

Locations

1 site across 1 country: China